SCA informed that the company’s Annual General Meeting of shareholders voted in favor of the Board of Director’s proposal to split the Group into two listed companies. According to the announcement, one of these will continue to operate as SCA, an efficient and well-invested forest products company that will include the forest products operations and all forest land currently owned by the Group. At the same time, SCA’s hygiene business, including the current business areas of Personal Care (including the recently acquired BSN medical) and Tissue will become a leading global hygiene and health company operating under the name Essity.
The split of the company will be carried out at a suitable time following completion of the listing process, but no later than in the second half of 2017. In addition to their existing shareholding, SCA’s shareholders will also receive shares in the newly listed hygiene and health company Essity in connection with the listing.
In 2016, the hygiene business accounted for approximately 86% of the Group’s net sales and the forest products business for approximately 14%.
SCA owns 2.6 million hectares of forest in Northern Sweden, an area corresponding to about 5% of Sweden, making it the largest private forest holding in Europe. With this unique resource as the foundation, SCA has developed a well-invested, resource-efficient industrial operation, designed to generate the highest possible value from the forest using all parts of the tree. The forest products business produces solid-wood products, pulp, kraftliner, publication papers and renewable energy.
Essity, following the split, will be a leading global hygiene and health company that develops, produces and sells personal care and tissueproducts. The company’s name stems from the words ‘essentials’ and ‘necessities’, a fitting name for the products the new hygiene and health company offers – everyday necessities. Essity’s vision is; dedicated to improving well-being through leading hygiene and health solutions. Its sales are conducted in approximately 150 countries under globally leading brands including TENA for incontinence products and Tork for Away-from-Home tissue, and under other well-known regional brands, such as Libero, Libresse, Lotus, Nosotras, Saba, Tempo, Vinda and Zewa. With the acquisition of BSN medical, a leading medical solutions company, Essity is further strengthening its capabilities in the health arena with brands such as Leukoplast, Cutimed, JOBST, Delta Cast, Delta Lite and Actimove.
Magnus Groth, currently President and CEO of SCA and future President and CEO of the new hygiene and health company Essity, commented:
“I am pleased that the shareholders support the Board’s proposal regarding two separate listed companies. This will increase value for shareholders in the long-term through increased focus, customer value, development opportunities and enables each company to successfully realize its strategies. We look forward to an exciting future for our two strong listed companies.
Hygiene and health are necessities for better lives and our products and solutions play an essential role in improving well-being for people around the world.”
SCA was founded in 1929 as a forest products company operating in Sweden. Over the years, the company expanded geographically and into other business activities, such as paper products production, personal care, consumer tissue and Away-from-Home tissue.
Earlier SCA announced around SEK 950 million investment into tissue production in Mexico.
The company is a leading global hygiene and forest products company. The Group develops and produces sustainable personal care, tissue and forest products. Sales are conducted in about 100 countries under many strong brands, including the leading global brands TENA and Tork, and regional brands, such as Libero, Libresse, Lotus, Nosotras, Saba, Tempo and Vinda. As Europe’s largest private forest owner, SCA places considerable emphasis on sustainable forest management. The Group has about 44,000 employees. Sales in 2015 amounted to more than SEK 115 billion (EUR 12.4 billion). SCA has its headquarters in Stockholm, Sweden, and is listed on NASDAQ OMX Stockholm.